ESTRO 2024 - Abstract Book

S1983

Clinical - Mixed sites, palliation

ESTRO 2024

Conclusion:

Clinic-wide collection of PROMs data from radiotherapy patients was feasible and an inclusion rate of 27% was achieved, though we aim to improve the requitement rate further. The usefulness of the outcomes analyses was however limited at this stage due to short follow-up and limited data. We plan to introduce treatment-specific PROMs as well as deploy data augmentation to the data currently available and utilize dose/volume, tumor histology/stage, radiomics and other data to produce more useful dose-response models as well as other outcomes models. In addition, we plan to introduce other PROMs questionnaires as well as application of questionnaires 3 months post-radiotherapy. Most patients that entered the PROMs program did not experience any deterioration in QoL after radiotherapy, which may be due to e.g. selection bias.

Keywords: PROMs

2719

Mini-Oral

Meta analysis of local control outcomes following SBRT of spine metastases

P Munck af Rosenschold 1,2 , M Dahele 3 , M Niyazi 4 , RS Guninski 5 , F Cuccia 6 , F Alongi 7 , N Andratschke 8 , C Belka 9 , D Bellut 10 , M Josipovic 11,12 , TE Kroese 5 , P Mancosu 13 , G Minniti 14 , U Ricardi 15 , Y Tsang 16 , A Sahgal 17 , M Guckenberger 5 1 Skåne University Hospital, Radiation physics, Department of Hematology, Oncology and Radiation Physics, Lund, Sweden. 2 Lund University, Medical Radiation Physics, Lund, Sweden. 3 Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Radiation Oncology and Cancer Center Amsterdam, Amsterdam, Netherlands. 4 University hospital Tübingen, Department of Radiation Oncology, Tübingen, Germany. 5 University of Zurich, Department of Radiation Oncology, Zurich, Switzerland. 6 ARNAS Civico Hospital, Radiation Oncology Unit, Palermo, Italy. 7 IRCCS Ospedale Sacro Cuore Don Calabria, Advanced Radiation Department, Negrar-Verona, Italy. 8 University Hospital Zurich, Department of Radiation Oncology, Zurich, Switzerland. 9 University Hospital, LMU Munich, Department of Radiation Oncology, Munich, Germany. 10 University Hospital Zurich, Department of Neurosurgery, Zurich, Switzerland. 11 University of Copenhagen, Department of Health and Medical Sciences, Copenhagen, Denmark. 12 Copenhagen University Hospital - Rigshospitalet, Department of Oncology, Copenhagen, Denmark. 13 IRCCS Humanitas Research Hospital, Radiation Oncology department, Milan, Italy. 14 Sapienza University of Rome, Department of Radiological Sciences, Oncology and Anatomical Pathology, Rome, Italy. 15 University of Turin, Department of Oncology, Turin, Italy. 16 Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, Canada. 17 Odette Cancer Center of the Sunnybrook Health Sciences Center, Department of Radiation Oncology, Toronto, Canada

Purpose/Objective: